BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10617249)

  • 1. Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17beta-estradiol and norgestimate on endometrial histology.
    Corson SL; Richart RM; Caubel P; Lim P
    Int J Fertil Womens Med; 1999; 44(6):279-85. PubMed ID: 10617249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy.
    Sulak PJ; Caubel P; Lane R
    Int J Fertil Womens Med; 1999; 44(6):286-96. PubMed ID: 10617250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.
    Ylikorkala O; Wahlström T; Caubel P; Lane R
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):654-60. PubMed ID: 12190841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O; Lim P; Caubel P
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms.
    Rozenberg S; Caubel P; Lim PC
    Int J Gynaecol Obstet; 2001 Mar; 72(3):235-43. PubMed ID: 11226444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women.
    Curran MP; Wagstaff AJ
    Treat Endocrinol; 2002; 1(2):127-9. PubMed ID: 15765628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
    Genazzani AR; Schmelter T; Schaefers M; Gerlinger C; Gude K
    Climacteric; 2013 Aug; 16(4):490-8. PubMed ID: 23531117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.
    Boerrigter PJ; van de Weijer PH; Baak JP; Fox H; Haspels AA; Kenemans P
    Maturitas; 1996 May; 24(1-2):63-71. PubMed ID: 8794436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
    Koninckx PR; Spielmann D
    Gynecol Endocrinol; 2005 Aug; 21(2):82-9. PubMed ID: 16294460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrium protection and acceptability of nasally administered continuously combined hormone therapy: a multicentre, multinational, double-blind trial in post-menopausal women evaluating three regimens of 17beta-estradiol and norethisterone when compared with an orally administered 17beta-estradiol norethisterone regimen.
    Rozenberg S; Pornel B; Koninckx PR; Palacios S; Christiansen C
    Hum Reprod; 2009 Jul; 24(7):1739-47. PubMed ID: 19351658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.
    Curran MP; Wagstaff AJ
    Drugs Aging; 2001; 18(11):863-85. PubMed ID: 11772126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of E2 and E2/norgestimate hormone therapy on elevated baseline lipids.
    Langer RD; Friedman AJ
    J Reprod Med; 2006 Aug; 51(8):610-6. PubMed ID: 16967629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A randomized case-control study on the influence of percutaneous estradiol and progestin in cyclic combined regimen on endometrium and vaginal bleeding pattern in Chinese early postmenopausal women].
    Sun A; Lin S; Wei Y
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1291-4. PubMed ID: 16200718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norgestimate. From the laboratory to three clinical indications.
    Henzl MR
    J Reprod Med; 2001 Jul; 46(7):647-61. PubMed ID: 11499185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel intermittent regimen of norgestimate to preserve the beneficial effects of 17beta-estradiol on lipid and lipoprotein profiles.
    Lobo RA; Zacur HZ; Caubel P; Lane R
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):41-9. PubMed ID: 10649155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic measurement of endometrial thickness during hormonal replacement therapy in postmenopausal women.
    Affinito P; Palomba S; Pellicano M; Sorrentino C; Di Carlo C; Morgera R; Arienzo MP; Nappi C
    Ultrasound Obstet Gynecol; 1998 May; 11(5):343-6. PubMed ID: 9644774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.